Number of shares and voting rights as at 31/10/2018

Europlasma declares the number of voting rights and shares comprising its share capital as at 31st October.

Read the press release


Half-year consolidated Resultats as at 30/06/2018

Europlasma announces its results for the half-year period ended 30/06/2018, which were subject to a limited review by the Board of Auditors and which were approved by the Board of Directors on October 30, 2018 .

Read the press release (in French)


Europlasma announces the reactivation of the financing agreement by issuance of convertible bonds

In the press release of September 3, 2018, Europlasma (the "Company") announced the suspension of the exercise of the third warrant given access to convertible bonds ("OCA") relating to the contract signed on July 17, 2018 (renewal of the contract concluded on February 9, 2018) with the Luxembourg fund European High Growth Opportunities Securitization Fund (the "Investor").

Read the press release (in French)


Number of shares and voting rights as at 30/09/2018

Europlasma declares the number of voting rights and shares comprising its share capital as at 30 September.

Read the press release (in French)


General Meeting of Shareholders on 27 September 2018

  • Quorum achieved: all resolutions suported by the Board of Directors have been approved
  • Group's activity update

Read the press release


Number of shares and voting rights as at 31/08/2018

Europlasma declares the number of voting rights and shares comprising its share capital as at 31st August.

Read the press release


Suspension of the automatic issuance of the 3rd warrant given access to convertible bonds

The company has suspended, today, the 3rd warrant given access to notes convertible into new shares (BEOCA).

Read the press release


Number of shares and voting rights as at 31/07/2018

Europlasma declares the number of voting rights and shares comprising its share capital as at 31st July.

Read the press release


Renewal of the convertible bonds financing contract

In the press release of February 9, 2018, Europlasma (the "Company") announced the conclusion of a convertible bond issue agreement (the "OCA") with the Luxembourg European High Growth Opportunity Securitization Fund (the "Investor"), renewable twice.

Read the release


Number of shares and voting rights as at 30/06/2018

Europlasma declares the number of voting rights and shares comprising its share capital as at 30th June.

Read the press release